Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Come forth CD1d: Hsp110 in the regulation of intestinal epithelial CD1d expression
Christopher V. Nicchitta
Christopher V. Nicchitta
Published September 1, 2003
Citation Information: J Clin Invest. 2003;112(5):646-648. https://doi.org/10.1172/JCI19641.
View: Text | PDF
Commentary

Come forth CD1d: Hsp110 in the regulation of intestinal epithelial CD1d expression

  • Text
  • PDF
Abstract

CD1d, a nonclassical MHC class I–like molecule, is prominently expressed on intestinal epithelial cells and is thought to function in the regulation of intestinal intraepithelial lymphocyte activity. Hsp110, an abundant heat shock protein present in essentially all mammalian tissues, has now been shown to upregulate CD1d expression in colonic tissue culture cell lines. Might this abundant chaperone serve an autocrine function in the regulation of CD1d expression?

Authors

Christopher V. Nicchitta

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Hypothetical model for an Hsp110 function in IEC CD1d expression. (I) In...
Hypothetical model for an Hsp110 function in IEC CD1d expression. (I) In this speculative model, Hsp110 release from IECs occurs during the physiological process of epithelial renewal and contributes, directly or indirectly, to the regulation of CD1d expression. In the case of normal (physiological) epithelial cell renewal, Hsp110 is released, whereupon it serves to signal normal (physiological) levels of CD1d expression. In this scenario, CD1d-directed NK T cell activation leads to the induction of IL-4 and IL-10 release and suppression of inflammatory responses. (II) In the case of accelerated (pathological) IEC death, Hsp110 release may be elevated, leading to enhanced levels of CD1d expression and perhaps alterations in the identity or relative quantity of CD1d ligands. In this scenario, NK T cells would be activated to yield release of the proinflammatory cytokines IFN-γ and TNF-α, thereby promoting the induction of inflammatory disease. TCR, T cell receptor.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts